COVID-19 Resources > COVID-19 Web Series > Opioid Use Disorder

 Webinar Slides

Wednesday, May 20, 2020 3:00 pm ET
Mitigating the Intersection of COVID-19
and Opioid Use Disorder

Keeping patients with opioid use disorder engaged in treatment in a rapidly altered practice dynamic due to COVID19 is critical. This discussion and interactive panel with clinicians, policy experts, and regulators will highlight the challenges faced in addressing the complex issues involved in such efforts. Emergency changes in regulations to lower barriers to care such as buprenorphine prescribing by telehealth and revised methadone dispensing can foster a more patient-centered approach and access to recovery care. But is it safe, what are the outcomes, and should it be continued?

 Moderator

_-2020_COVID_Webinar_Presenters/Nelson_2.jpg        

Lewis Nelson, MD, FACMT

Chair of the Department of Emergency Medicine, Rutgers New Jersey
Medical School, Newark NJ                                                                                            


 Panelists

_-2020_COVID_Webinar_Presenters/Brinks.jpg        

Scott A. Brinks

Regulatory Drafting & Policy Support Section, Drug Enforcement Agency,
U.S. Department of Justice, Arlington, VA                                                                       

_-2020_COVID_Webinar_Presenters/LaBelle.jpg        

Regina LaBelle, JD

Director, Addiction & Public Policy Initiative;
Distinguished Scholar, O'Neill Institute for National & Global Health Law,
Georgetown University Law Center, Washington, DC                                                        

_-2020_COVID_Webinar_Presenters/Miller.jpg        

Loren T. Miller

Section Chief, Diversion Liaison & Policy Section, Drug Enforcement Agency,
U.S. Department of Justice, Arlington, VA                                                                       

 

_-2020_COVID_Webinar_Presenters/Perrone.jpg        

Jeanmarie Perrone, MD, FACMT

Professor, Emergency Medicine and Medical Toxicology;
Director, Center for Addiction Medicine and Policy, 
Perelman School of Medicine at the University of Pennsylvania                                          
Philadelphia, PA                                                  

_-2020_COVID_Webinar_Presenters/Sue.jpg        

Kimberly Sue, MD, PhD

Medical Director, Harm Reduction Coalition, New York, NY                                                



Series Partners

American Academy of Clinical Toxicology (AACT) | American Academy of Emergency Medicine (AAEM) | American Association of Poison Control Centers (AAPCC) | American College of Medical Toxicology (ACMT) | Asia Pacific Association of Medical Toxicologists (APAMT) | European Association of Poison Centers and Clinical Toxicologists (EAPCCT) | Middle East & North Africa Clinical Toxicology Association (MENATOX)  

images/COVID Series LOGOS